Emyria Ltd (EMD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.316x

Based on the latest financial reports, Emyria Ltd (EMD) has a cash flow conversion efficiency ratio of -0.316x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.67 Million ≈ $-1.18 Million USD) by net assets (AU$5.31 Million ≈ $3.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EMD net asset quality index to measure how much of total assets are equity-financed.

Emyria Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Emyria Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check EMD cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Emyria Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Emyria Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Hudson Acquisition I Corp. Common Stock
NASDAQ:HUDA
0.012x
Sangji Caelum Inc
KQ:042940
-0.054x
Fusemachines Inc. Common stock
NASDAQ:FUSE
1.481x
Niche Capital Emas Holdings
KLSE:7139
0.013x
Trident Digital Tech Holdings Ltd American Depository Shares
NASDAQ:TDTH
0.658x
CryoCell International Inc
NYSE MKT:CCEL
-0.171x
KPS Consortium Bhd
KLSE:9121
0.004x
Foremost Lithium Resource & Technology Ltd. Common stock
NASDAQ:FMST
-0.050x

Annual Cash Flow Conversion Efficiency for Emyria Ltd (2018–2025)

The table below shows the annual cash flow conversion efficiency of Emyria Ltd from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Emyria Ltd (EMD) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$5.31 Million
≈ $3.75 Million
AU$-2.70 Million
≈ $-1.91 Million
-0.510x +71.14%
2024-06-30 AU$2.43 Million
≈ $1.72 Million
AU$-4.28 Million
≈ $-3.03 Million
-1.767x -218.22%
2023-06-30 AU$6.79 Million
≈ $4.81 Million
AU$-3.77 Million
≈ $-2.67 Million
-0.555x +35.34%
2022-06-30 AU$6.32 Million
≈ $4.47 Million
AU$-5.43 Million
≈ $-3.84 Million
-0.859x -56.53%
2021-06-30 AU$7.18 Million
≈ $5.08 Million
AU$-3.94 Million
≈ $-2.79 Million
-0.549x +53.40%
2020-06-30 AU$3.78 Million
≈ $2.68 Million
AU$-4.45 Million
≈ $-3.15 Million
-1.177x +77.33%
2019-06-30 AU$499.54K
≈ $353.46K
AU$-2.59 Million
≈ $-1.83 Million
-5.191x -69937.67%
2018-06-30 AU$2.81 Million
≈ $1.99 Million
AU$-20.82K
≈ $-14.73K
-0.007x --

About Emyria Ltd

AU:EMD Australia Health Information Services
Market Cap
$27.39 Million
AU$38.71 Million AUD
Market Cap Rank
#24055 Global
#942 in Australia
Share Price
AU$0.05
Change (1 day)
-2.04%
52-Week Range
AU$0.03 - AU$0.07
All Time High
AU$0.50
About

Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-… Read more